These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 1878721

  • 1. Strategies for acute myelogenous leukemia.
    Gale RP, Butturini A.
    Bone Marrow Transplant; 1991; 7 Suppl 2():58. PubMed ID: 1878721
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of acute myelogenous leukaemia.
    Löwenberg B.
    J Intern Med Suppl; 1997; 740():17-22. PubMed ID: 9350177
    [Abstract] [Full Text] [Related]

  • 3. Chemotherapy versus transplantation: I. Acute myelogenous leukemia.
    Gale RP, Butturini A.
    Haematologica; 1989; 74(1):1-4. PubMed ID: 2498172
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The therapy of acute myelogenous leukemia, a major challenge of onco-hematology.
    Boiron M.
    Pathol Biol (Paris); 1986 Mar; 34(3):153-6. PubMed ID: 3517783
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Allogeneic and autologous bone marrow transplantation for patients with acute non-lymphoblastic leukemia in first complete remission. The Genoa experience on 119 patients.
    Carella AM, Piatti G, Frassoni F, Maraone MP, Van Lint MT, Bacigalupo A.
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():55. PubMed ID: 2202469
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Post-remission treatment of acute myelogenous leukemia.
    Löwenberg B.
    N Engl J Med; 1995 Jan 26; 332(4):260-2. PubMed ID: 7808494
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Allogeneic or autologous bone marrow transplantation for acute non-lymphocytic leukemia in first remission.
    Ferrant A, Doyen C, Delannoy A, Cornu G, Martiat P, Latinne D, De Bruyère M, Bosly A, Michaux JL, Sokal G.
    Bone Marrow Transplant; 1991 Apr 26; 7(4):303-9. PubMed ID: 2070137
    [Abstract] [Full Text] [Related]

  • 15. [Comparison between bone marrow autograft and intensive chemotherapy as treatment for maintenance of complete remission in acute myeloblastic leukemia in the adult. GOELAM Group].
    Harousseau JL, Pignon B, Cahn JY.
    Nouv Rev Fr Hematol (1978); 1993 Jun 26; 35(3):197-8. PubMed ID: 8337124
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Follow-up 26 years after treatment for acute myelogenous leukemia.
    Clift RA, Thomas ED, Seattle Marrow Transplant Team.
    N Engl J Med; 2004 Dec 02; 351(23):2456-7. PubMed ID: 15575071
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Relative value of allogeneic BMT, autologous BMT and intensive chemotherapy during the first complete remission (CR) of acute myelogenous leukemia (AML). An interim analysis of the AML8 EORTC-GIMEMA protocol.
    Zittoun R, Mandelli F, De Witte T, Willemze R, Tura S.
    Bone Marrow Transplant; 1990 Jul 02; 6 Suppl 1():56-8. PubMed ID: 2202470
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.